Aragen Bioscience, Inc. — Form D
Aragen Bioscience, Inc. of MORGAN HILL, CA, a company, filed a Form D exempt-offering notice with the SEC on 2014-01-28. The offering totals $3.7M, of which $2.7M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-01-28
- Form: D
- Accession: 0000897069-14-000020
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $2.7M
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2014-01-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-210871
Issuer
- Name: Aragen Bioscience, Inc.
- CIK: 0001594773
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Address: 380 WOODVIEW AVENUE, MORGAN HILL, CA, 95037
- Phone: (408) 779-1700, #13
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Manmahesh C Kantipudi | Director | Morgan Hill, CA |
| William R Srigley | Director | Morgan Hill, CA |
| William R Srigley | Executive Officer | Morgan Hill, CA |
| Christian C Simonsen | Executive Officer | Morgan Hill, CA |
| J.B. C Gupta | Director | Morgan Hill, CA |
Other filings by this issuer (1)
More